Who Paid My Doc
Michael Patterson
Hospice and Palliative Medicine Columbus, OH Doctor of Osteopathy
NPI 1891792248 CMS profile 131378
800 McConnell Rd, Columbus, OH 43214
General payments
$7,095
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Michael Patterson of Columbus, OH is reported in the CMS Open Payments database as having received $7,095 across 23 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Hospice and Palliative Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $13 | 2 | |
| 2024 | General | $263 | 1 | |
| 2023 | General | $24 | 1 | |
| 2021 | General | $31 | 2 | |
| 2019 | General | $6,765 | 17 |
Beside peers
- Michael Patterson
- Hospice and Palliative Medicine median
- Middle half of Hospice and Palliative Medicine
- National median
In program year 2025, general payments to Michael Patterson were reported at $13. Among 378 Hospice and Palliative Medicine profiles paid that year, the median was $78 and the middle half received between $28 and $160.
Show as a table
| Year | Michael Patterson | Hospice and Palliative Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $6,765 | $80 | $22–$147 | $163 |
| 2020 | $0 | $36 | $18–$121 | $114 |
| 2021 | $31 | $64 | $23–$194 | $132 |
| 2022 | $0 | $67 | $22–$158 | $149 |
| 2023 | $24 | $65 | $25–$149 | $160 |
| 2024 | $263 | $75 | $25–$158 | $164 |
| 2025 | $13 | $78 | $28–$160 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 78 drugsPart D claims
2,396
Drug cost
$283,744
Branded share of claims
22.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ingrezza Valbenazine Tosylate | Brand | 16 | $144,033 | |
| Eliquis Apixaban | Brand | 122 | $37,972 | |
| Januvia Sitagliptin Phosphate | Brand | 55 | $16,606 | |
| Avycaz Ceftazidime/Avibactam | Brand | 19 | $16,386 | |
| Vraylar Cariprazine Hcl | Brand | 11 | $7,788 | |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | Brand | 23 | $7,393 | |
| Nuedexta Dextromethorphan Hbr/Quinidine | Brand | 19 | $6,313 | |
| Combivent Respimat Ipratropium/Albuterol Sulfate | Brand | 12 | $6,244 | |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | Brand | 15 | $4,118 | |
| Cefepime Hcl | Generic | 15 | $2,861 |
The 10 drugs with the highest cost, of 78 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 104,182 Part D prescribers listed as Internal Medicine; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 14 billing codesPaid by Medicare
$49,981
Medicare patients
236
Services billed
650
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 61% | |
| Chronic kidney disease | 53% | |
| Ischemic heart disease | 50% | |
| Heart failure | 46% | |
| Depression | 46% | |
| Diabetes | 45% | |
| COPD | 42% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospice and Palliative Medicine in Ohio
Bassam Estfan
Hospice and Palliative Medicine · Cleveland, OH
Amit Patel
Hospice and Palliative Medicine · Columbus, OH
Saurabh Khurana
Hospice and Palliative Medicine · Columbus, OH
Ahed Makhoul
Hospice and Palliative Medicine · Cleveland, OH
Adriane Teach
Hospice and Palliative Medicine · Wooster, OH
Madeline Hudak
Hospice and Palliative Medicine · Canton, OH
Related records
Hospice and Palliative Medicine in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Hospice and Palliative Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.